The role of IL-13 in exercise-induced skeletal muscle metabolic remodeling and its protein function study

Summary

Exercise is a crucial approach for preventing and improving metabolic syndrome and related diseases. Its beneficial effects independent of weight changes suggest the involvement of humoral factors in regulating metabolic adaptations during exercise. Recent studies indicate that the type 2 cytokine IL-13 is induced during exercise and, by binding to its receptor IL-13Rα1 and activating the transcription factor Stat3 signaling, drives a shift in skeletal muscle fuel utilization from glycogen dependence to fatty acid oxidation and mitochondrial respiration. Loss of IL-13 signaling impairs exercise-mediated metabolic benefits, while enhancing its signaling can mimic the effects of exercise training, highlighting the central regulatory role of IL-13 protein in exercise-induced metabolic adaptations.

I. Biological Characteristics and Sources of IL-13

IL-13 is primarily secreted by activated T cells, type 2 innate lymphoid cells, and certain granulocytes. Traditionally recognized for its key role in allergic responses and type 2 immune responses, its function in metabolic regulation has gained increasing attention, particularly in skeletal muscle energy metabolism remodeling.

II. Exercise-Induced IL-13 Expression and Metabolic Remodeling

Exercise upregulates IL-13 expression in skeletal muscle, which activates the downstream Stat3 signaling pathway through its receptor complex IL-13Rα1/IL-4Rα. This signaling cascade induces a shift in muscle metabolic programs, manifested as:

1. Glycogen Preservation: Reduced reliance on glycogen breakdown during exercise;
2. Enhanced Fatty Acid Oxidation: Promotes fat as an energy source;
3. Promotion of Mitochondrial Biogenesis and Respiration: Improves aerobic metabolic capacity and optimizes energy utilization efficiency.

III. Functional Validation of IL-13 Signaling in Exercise-Induced Metabolic Adaptations

Gene knockout studies show that IL-13-deficient mice (Il13⁻/⁻) fail to exhibit normal enhancements in mitochondrial biogenesis, running endurance, or glucose improvement after exercise training. Conversely, enhancing IL-13 signaling in muscles significantly increases running distance, glucose tolerance, and mitochondrial activity in untrained mice, mimicking the effects of endurance exercise. Further studies confirm that loss of IL-13Rα1 or Stat3 leads to reduced exercise capacity, underscoring the critical role of this signaling pathway in exercise adaptation.

IV. Research Value of IL-13 Protein in Metabolic Regulation

Based on these mechanisms, IL-13 protein has become an important target for studying exercise-induced metabolic adaptations and developing related interventions. It holds clear research and application prospects in the following areas:

1. Mechanistic Insights: Serves as a signaling node to study the intersection of exercise, immunity, and metabolism;
2. Exercise-Mimicking Strategies: Explores the possibility of simulating exercise benefits through IL-13 signaling modulation;
3. Disease Intervention: Provides new therapeutic targets for metabolic syndrome, sarcopenia, and insulin resistance.

V. Conclusion

As an exercise-induced humoral factor, IL-13 drives a shift in skeletal muscle metabolism from glycolysis to fatty acid oxidation and mitochondrial respiration by activating the IL-13Rα1/Stat3 signaling axis, thereby optimizing energy utilization, enhancing exercise endurance, and improving metabolic health. This research not only reveals a novel function of immune factors in exercise physiology but also provides a critical foundation for IL-13 protein-based metabolic regulation studies and applications.

VI. Which Manufacturers Provide IL-13 Protein?

Nanjing U-Protein's independently developed IL-13 Protein, Human (Catalog No.: UA040506) is a high-purity, high-activity recombinant human interleukin-13 (IL-13) produced using a mammalian expression system, with spatial conformation and post-translational modifications consistent with the native protein. This product has undergone rigorous validation for purity, stability, and bioactivity, making it an essential tool for studying type 2 immune responses, allergic diseases, asthma mechanisms, and targeted drug development.

Nanjing U-Protein is committed to providing high-quality core protein tools for immunology research, disease model construction, and innovative drug development. For detailed technical specifications, activity validation data, or application inquiries regarding IL-13 Protein, Human (Catalog No.: UA040506), please feel free to contact us.